Sign in
PBMWW Stock Price, Chart, Stats & News
Psyence Biomedical Ltd. Warrant
Save
Psyence Biomedical Ltd. Warrant (PBMWW) does not currently pay a dividend.
1,646
Market cap
–
Current P/E
–
Forward P/E
PBMWW chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -4.78% |
ROE | -11.53% |
D/E | – |
Interest coverage ratio | -411.78x |
PBMWW valuation
P/E | – |
P/S | – |
P/B | 0.32x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.06x |
EV multiple | -12.02x |
About
Psyence Biomedical Ltd. focuses on developing psychedelic medications derived from botanical psilocybin. The company is also investigating the use of natural psilocybin to alleviate adjustment disorder in patients with incurable cancer who are undergoing palliative care. Its primary product candidate, PEX010, is a capsule containing naturally sourced psilocybin, which is currently undergoing a Phase IIb clinical study.
Similar securities
Based on sector and market capitalization
Report issue